Hedge Fund - Perceptive Advisors
Bridgebio Pharma Inc. (BBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $26.25 |
| 2 | 2024 - Q2 (2024-06-30) | $30,784,714 | 0.74% | 1,215,346 | $27.34 |
| 3 | 2024 - Q1 (2024-03-31) | $43,660,060 | 0.76% | 1,412,033 | $34.01 |
| 4 | 2023 - Q4 (2023-12-31) | $70,604,425 | 1.57% | 1,748,933 | $30.03 |
| 5 | 2023 - Q3 (2023-09-30) | $46,119,363 | 1.53% | 1,748,933 | $28.38 |
| 6 | 2023 - Q2 (2023-06-30) | $30,081,647 | 0.87% | 1,748,933 | $15.05 |
| 7 | 2023 - Q1 (2023-03-31) | $31,618,607 | 0.93% | 1,907,033 | $11.66 |
| 8 | 2022 - Q4 (2022-12-31) | $12,931,391 | 0.36% | 1,697,033 | $9.57 |
| 9 | 2022 - Q3 (2022-09-30) | $16,869,000 | 0.48% | 1,697,033 | $10.39 |
| 10 | 2022 - Q2 (2022-06-30) | $15,409,000 | 0.48% | 1,697,033 | $8.36 |
| 11 | 2022 - Q1 (2022-03-31) | $38,969,000 | 0.78% | 3,839,380 | $10.26 |
| 12 | 2021 - Q4 (2021-12-31) | $118,907,000 | 1.83% | 7,128,755 | $42.31 |
| 13 | 2021 - Q3 (2021-09-30) | $363,567,000 | 5.28% | 7,756,928 | $53.60 |
| 14 | 2021 - Q2 (2021-06-30) | $472,862,000 | 6.13% | 7,756,928 | $57.11 |
| 15 | 2021 - Q1 (2021-03-31) | $477,827,000 | 6.04% | 7,756,928 | $65.42 |
| 16 | 2020 - Q4 (2020-12-31) | $476,883,000 | 5.11% | 6,706,268 | $48.24 |
| 17 | 2020 - Q3 (2020-09-30) | $251,619,000 | 3.67% | 6,706,268 | $31.46 |
| 18 | 2020 - Q2 (2020-06-30) | $218,691,000 | 3.54% | 6,706,268 | $30.46 |
| 19 | 2020 - Q1 (2020-03-31) | $194,481,000 | 5.06% | 6,706,268 | $31.01 |
| 20 | 2019 - Q4 (2019-12-31) | $142,273,000 | 2.82% | 6,706,268 | $27.72 |
| 21 | 2019 - Q3 (2019-09-30) | $143,983,000 | 3.87% | 6,706,268 | $27.66 |
| 22 | 2019 - Q2 (2019-06-30) | $180,868,000 | 4.15% | 6,706,268 | $27.26 |
The displayed share prices are average quarterly stock market prices.